Showing results (321-330 of 441) with videos related to

Sort By:
Pageof 45
Neuro-Oncology Practice|December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Nature Communications|January 28, 2021
IDH1 mutations induce organelle defects via dysregulated phospholipidsAdrian Lita, Artem Pliss, Andrey Kuzmin, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Cancer & Metabolism|October 26, 2020
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibitionVictor Ruiz-Rodado, Adrian Lita, Tyrone Dowdy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastomaJohn H Sampson, Amy B Heimberger, Gary E Archer, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2017
Novel Targeting of Transcription and Metabolism in GlioblastomaYu-Ting Su, Robert Chen, Herui Wang, et al.
Pageof 45